Literature DB >> 7261419

Thyroid hormones in acute myocardial infarction.

W M Wiersinga, K I Lie, J L Touber.   

Abstract

Thyroid hormones were serially measured over a 2-week period in thirty-four consecutive patients with acute myocardial infarction (AMI). A transient increase in plasma rT3 and a decrease in plasma T3 was found, with the maximum changes occurring on the third day after the onset of AMI. The changes in plasma rT3 and T3 were greater in the seventeen patients with a complicated AMI (mean peak SGOT 145 mu/l) than in the seventeen patients with an uncomplicated AMI (mean peak SGOT 79 mu/l). A correlation was found between infarct size (as estimated by the peak SGOT value) and the following indices: delta r T3, delta T3, highest rT3/t3 and highest rT3/T4 ratios. A transient increase in plasma TSH (peak on days 4 and 5) and in plasma T4 and FT4 index (peak on days 6 and 7) was also observed, whereas T3 resin uptake (T3U) decreased. These findings suggest that the following sequence of events occurs in thyroid hormone metabolism during AMI: (1) inhibition of the 5'-deiodination of T4, resulting in increased plasma rT3 and decreased plasma T3 values, and in a lower metabolic clearance of T4. (2) Increased secretion of TSH (provoked by the lower T3 levels) resulting in increased thyroidal secretion of T4 and T3, which is then switched off by the negative feedback of thyroid hormones on the pituitary.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261419     DOI: 10.1111/j.1365-2265.1981.tb00622.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Hormonal changes in non-endocrine disease.

Authors:  C G Semple
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

2.  Free thyroxine in myocardial infarction.

Authors:  O J Kirkeby; C Risöe; K Kirkeby
Journal:  Experientia       Date:  1984-01-15

3.  "Low T3-syndrome" in acute myocardial infarction--relationship to beta-adrenergic blockade and clinical course.

Authors:  F Pedersen; H Perrild; S L Rasmussen; L Skovsted
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  [Non-thyroid illness" or changed thyroid hormone parameter syndrome with non-thyroid illnesses].

Authors:  W Reinhardt; K Mann
Journal:  Med Klin (Munich)       Date:  1998-11-15

Review 5.  Physiopathological aspects of the subclinical alterations of thyroid function associated with acute coronary syndromes.

Authors:  C S Stamate; A M Andronescu; A C Nechita; C Delcea; E M Mihu; M M Vintila
Journal:  J Med Life       Date:  2013-12-25

Review 6.  Mitochondria as key targets of cardioprotection in cardiac ischemic disease: role of thyroid hormone triiodothyronine.

Authors:  Francesca Forini; Giuseppina Nicolini; Giorgio Iervasi
Journal:  Int J Mol Sci       Date:  2015-03-19       Impact factor: 5.923

Review 7.  Nonthyroidal Illness Syndrome Across the Ages.

Authors:  Lies Langouche; An Jacobs; Greet Van den Berghe
Journal:  J Endocr Soc       Date:  2019-10-16

8.  Low T3 State Is Correlated with Cardiac Mitochondrial Impairments after Ischemia Reperfusion Injury: Evidence from a Proteomic Approach.

Authors:  Francesca Forini; Nadia Ucciferri; Claudia Kusmic; Giuseppina Nicolini; Antonella Cecchettini; Silvia Rocchiccioli; Lorenzo Citti; Giorgio Iervasi
Journal:  Int J Mol Sci       Date:  2015-11-06       Impact factor: 5.923

9.  Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats.

Authors:  Francesca Forini; Vincenzo Lionetti; Hossein Ardehali; Angela Pucci; Federica Cecchetti; Mohsen Ghanefar; Giuseppina Nicolini; Yoshihiko Ichikawa; Monica Nannipieri; Fabio A Recchia; Giorgio Iervasi
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.